8-22164004-G-A

Variant summary

Our verdict is Benign. Variant got -18 ACMG points: 2P and 20B. PM1BP4_StrongBP6_Very_StrongBA1

The NM_001317778.2(SFTPC):​c.539G>A​(p.Ser180Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.311 in 1,612,222 control chromosomes in the GnomAD database, including 80,274 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.26 ( 5934 hom., cov: 34)
Exomes 𝑓: 0.32 ( 74340 hom. )

Consequence

SFTPC
NM_001317778.2 missense

Scores

17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 0.418
Variant links:
Genes affected
SFTPC (HGNC:10802): (surfactant protein C) This gene encodes the pulmonary-associated surfactant protein C (SPC), an extremely hydrophobic surfactant protein essential for lung function and homeostasis after birth. Pulmonary surfactant is a surface-active lipoprotein complex composed of 90% lipids and 10% proteins which include plasma proteins and apolipoproteins SPA, SPB, SPC and SPD. The surfactant is secreted by the alveolar cells of the lung and maintains the stability of pulmonary tissue by reducing the surface tension of fluids that coat the lung. Multiple mutations in this gene have been identified, which cause pulmonary surfactant metabolism dysfunction type 2, also called pulmonary alveolar proteinosis due to surfactant protein C deficiency, and are associated with interstitial lung disease in older infants, children, and adults. Alternatively spliced transcript variants encoding different protein isoforms have been identified.[provided by RefSeq, Feb 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -18 ACMG points.

PM1
In a hotspot region, there are 3 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 1 benign, 6 uncertain in NM_001317778.2
BP4
Computational evidence support a benign effect (MetaRNN=0.0031855404).
BP6
Variant 8-22164004-G-A is Benign according to our data. Variant chr8-22164004-G-A is described in ClinVar as [Benign]. Clinvar id is 165212.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-22164004-G-A is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.327 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
SFTPCNM_001317778.2 linkuse as main transcriptc.539G>A p.Ser180Asn missense_variant 5/6 ENST00000679463.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
SFTPCENST00000679463.1 linkuse as main transcriptc.539G>A p.Ser180Asn missense_variant 5/6 NM_001317778.2 A1

Frequencies

GnomAD3 genomes
AF:
0.262
AC:
39861
AN:
152142
Hom.:
5939
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.110
Gnomad AMI
AF:
0.355
Gnomad AMR
AF:
0.277
Gnomad ASJ
AF:
0.297
Gnomad EAS
AF:
0.336
Gnomad SAS
AF:
0.282
Gnomad FIN
AF:
0.325
Gnomad MID
AF:
0.357
Gnomad NFE
AF:
0.330
Gnomad OTH
AF:
0.285
GnomAD3 exomes
AF:
0.299
AC:
74229
AN:
248638
Hom.:
11540
AF XY:
0.302
AC XY:
40797
AN XY:
135132
show subpopulations
Gnomad AFR exome
AF:
0.104
Gnomad AMR exome
AF:
0.264
Gnomad ASJ exome
AF:
0.308
Gnomad EAS exome
AF:
0.321
Gnomad SAS exome
AF:
0.271
Gnomad FIN exome
AF:
0.330
Gnomad NFE exome
AF:
0.332
Gnomad OTH exome
AF:
0.313
GnomAD4 exome
AF:
0.316
AC:
461276
AN:
1459962
Hom.:
74340
Cov.:
50
AF XY:
0.316
AC XY:
229605
AN XY:
726288
show subpopulations
Gnomad4 AFR exome
AF:
0.103
Gnomad4 AMR exome
AF:
0.265
Gnomad4 ASJ exome
AF:
0.312
Gnomad4 EAS exome
AF:
0.320
Gnomad4 SAS exome
AF:
0.275
Gnomad4 FIN exome
AF:
0.323
Gnomad4 NFE exome
AF:
0.328
Gnomad4 OTH exome
AF:
0.310
GnomAD4 genome
AF:
0.262
AC:
39857
AN:
152260
Hom.:
5934
Cov.:
34
AF XY:
0.262
AC XY:
19533
AN XY:
74448
show subpopulations
Gnomad4 AFR
AF:
0.110
Gnomad4 AMR
AF:
0.276
Gnomad4 ASJ
AF:
0.297
Gnomad4 EAS
AF:
0.336
Gnomad4 SAS
AF:
0.282
Gnomad4 FIN
AF:
0.325
Gnomad4 NFE
AF:
0.330
Gnomad4 OTH
AF:
0.285
Alfa
AF:
0.318
Hom.:
12366
Bravo
AF:
0.254
TwinsUK
AF:
0.322
AC:
1194
ALSPAC
AF:
0.326
AC:
1255
ESP6500AA
AF:
0.105
AC:
432
ESP6500EA
AF:
0.335
AC:
2800
ExAC
AF:
0.298
AC:
36094
Asia WGS
AF:
0.287
AC:
997
AN:
3478
EpiCase
AF:
0.339
EpiControl
AF:
0.336

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Benign, criteria provided, single submitterclinical testingInvitaeJan 31, 2024- -
Benign, criteria provided, single submitterclinical testingGeneDxJul 09, 2018This variant is associated with the following publications: (PMID: 14735158) -
not specified Benign:1
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineJun 11, 2013- -
Interstitial lung disease 2 Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJun 14, 2016- -
Pulmonary Surfactant Metabolism Dysfunction, Dominant Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJun 14, 2016- -
Osteogenesis Imperfecta, Recessive Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJun 14, 2016- -
Hereditary pulmonary alveolar proteinosis Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsOct 26, 2015This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Surfactant metabolism dysfunction, pulmonary, 2 Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaMar 06, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.087
BayesDel_addAF
Benign
-0.65
T
BayesDel_noAF
Benign
-0.56
CADD
Benign
12
DANN
Benign
0.97
DEOGEN2
Benign
0.0082
T;T;T
Eigen
Benign
-0.58
Eigen_PC
Benign
-0.46
FATHMM_MKL
Benign
0.27
N
LIST_S2
Benign
0.49
T;T;T
MetaRNN
Benign
0.0032
T;T;T
MetaSVM
Benign
-1.1
T
MutationTaster
Benign
0.63
P;P;P;P;P;P
PrimateAI
Benign
0.47
T
PROVEAN
Benign
0.97
N;N;N
REVEL
Benign
0.12
Sift
Benign
0.42
T;T;T
Sift4G
Benign
0.73
T;T;T
Vest4
0.057
MPC
0.41
ClinPred
0.011
T
GERP RS
2.3
gMVP
0.58

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1124; hg19: chr8-22021517; COSMIC: COSV59345528; COSMIC: COSV59345528; API